SEC Form 4 · accession 0001209191-16-155276
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick G Enright
Director · 10% Owner
Period of report
Dec 12, 2016
Accepted (ET)
Dec 14, 2016 · 8:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 12, 2016 | J | 204,210 | $0.00 | A | 204,210 | D | |
| Common StockF2,F3 | holding | — | — | — | 10,740,720 | I | By LVP | |
| Common StockF2,F3 | holding | — | — | — | 215,282 | I | By LCA |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On November 28, 2016, Longitude Venture Partners, L.P. ("LVP") and Longitude Capital Partners, L.P. ("LCA") completed a pro rata distribution of shares of common stock of the Issuer to its partners for no consideration. Longitude Capital Partners, LLC ("Longitude Capital"), the sole general partner of LVP and LCA, received a pro rata allocation of the distributed shares in accordance with its ownership, and on December 12, 2016, further distributed its allocation to its managing members. Patrick G. Enright, as a managing member of Longitude Capital, acquired the shares noted in this Form through such distribution.
- F2Reflects holdings of shares of common stock of the Issuer held of record by LVP and LCA. Mr. Enright disclaims beneficial ownership of the securities of the Issuer held of record by LVP and LCA, except to the extent of his pecuniary interest therein.
- F3The holdings in this Form 4 have been adjusted to reflect a previous transfer of 94,129 shares from LVP to LCA.